{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:07:47Z","timestamp":1795158467777,"version":"4.10.3"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2511,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatrics International"],"published-print":{"date-parts":[[2001,8,22]]},"abstract":"<jats:p> <jats:bold>Abstract<\/jats:bold>\n          <jats:bold>\n            <jats:italic>Background<\/jats:italic>\n          <\/jats:bold>: The CD44, a cell surface proteoglycan, participates in a variety of function including tumor dissemination and metastasis. However, there are no available data on the prognostic significance of CD44 expression of tumor tissue correlated with serum sCD44 level in childhood leukemias and lymphomas.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Methods<\/jats:italic>\n          <\/jats:bold>: Serum levels and leukemic cell tumor tissue expression of CD44 were detected in 54 children with acute leukemia and malignant lymphoma. Serum samples were obtained from all patients before treatment and during remission. Twelve age\u2010matched healthy children were included as a control group.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Results<\/jats:italic>\n          <\/jats:bold>: The serum CD44 levels were significantly higher in patients with Hodgkin\u2019s disease (HD), non\u2010Hodgkin\u2019s lymphoma (NHL), Burkitt\u2019s lymphoma (BL) and acute lymphoblastic leukemia (ALL) than those in the control group. The median values were 1627.0, 1336.0, 1318.5, 1730.4, 902.7 ng\/mL, respectively, and <jats:italic>P<\/jats:italic>&lt;0.001, <jats:italic>P<\/jats:italic>&lt;0.01, <jats:italic>P<\/jats:italic>&lt;0.01, <jats:italic>P<\/jats:italic>&lt;0.05 in comparisons, respectively. However, there was no significant difference between acute myeloid leukemia (AML) and the control group (median values: 900.3 and 902.7 ng\/mL, respectively, <jats:italic>P<\/jats:italic>&gt;0.05). Serum sCD44 levels significantly declined in HD, NHL and ALL patients who were in complete remission (median values: 684.0, 573.8 and 1101.1 ng\/mL, respectively, <jats:italic>P<\/jats:italic>&lt;0.05 in each comparison). Patients with HD had higher levels of serum sCD44 and correlated well with higher erythrocyte sedimentation rate (ESR), B\u2010symptoms and advanced\u2010stage disease (<jats:italic>P<\/jats:italic>&lt;0.05, <jats:italic>P<\/jats:italic>&lt;0.05 and <jats:italic>P<\/jats:italic>&lt;0.01, respectively). Expression of CD44 was significantly high in patients with HD and NHL who were in advanced stages of disease. High serum CD44 level was also associated with high tumor tissue expression of CD44 in patients with HD and BL. In addition, patients with higher levels of serum sCD44, had a poorer outcome and survival than those with lower sCD44 levels in HD and NHL groups.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Conclusions<\/jats:italic>\n          <\/jats:bold>: A high serum sCD44 level and\/or tumor tissue expression at diagnosis is associated with poor prognostic criteria and\/or unfavorable outcome in childhood leukemias and lymphomas.<\/jats:p>","DOI":"10.1046\/j.1442-200x.2001.01415.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T16:51:30Z","timestamp":1047487890000},"page":"354-360","source":"Crossref","is-referenced-by-count":12,"title":["Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: Correlation with prognostic criteria and survival"],"prefix":"10.1111","volume":"43","author":[{"given":"Nurdan","family":"Ta\u00e7yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan O.","family":"\u00c7avdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclsan","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"G\u00f6zda\u015foglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulya","family":"Ertem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feride","family":"Duru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydan","family":"Ikinciogullari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Babacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isinsu","family":"Kuzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Cin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.105.2.983"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.113.1.207"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.24.12160"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60537-4"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-78253-4_17"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/304030a0"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.5.2863"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.4.897"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115205"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711760308"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood.V73.4.885.885","article-title":"Expression of lymphocyte homing receptor as a mechanism of dissemination in non\u2010Hodgkin\u2019s lymphoma.","volume":"73","author":"Pals ST","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood.V73.2.596.596","article-title":"Characterization of the serum In (Lu)\u2010related antigen: Identification of a serum protein related to erythrocyte p80.","volume":"73","author":"Lucas MG","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V84.1.238.238","article-title":"Serum CD44 in malignant lymphoma: An association with treatment response.","volume":"84","author":"Ristamaki R","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1182\/blood.V90.10.4039","article-title":"Elevated serum CD44 level is associated with unfavorable outcome in non\u2010Hodgkin\u2019s lymphoma.","volume":"90","author":"Ristamaki R","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1182\/blood.V91.9.3401","article-title":"A strong expression of CD44\u20136v correlates with shorter survival of patients with acute myeloid Leukemia.","volume":"91","author":"Legras S","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/088800199277470"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03563.x"},{"key":"e_1_2_6_19_2","first-page":"1311","article-title":"Report of the nomenclature committee.","volume":"26","author":"Lukas RJ","year":"1966","journal-title":"Cancer Res."},{"key":"e_1_2_6_20_2","first-page":"601","article-title":"Histopathological definition of Burkitt\u2019s tumor.","volume":"40","author":"Berard C","year":"1969","journal-title":"Bull. World Health. Organ."},{"key":"e_1_2_6_21_2","first-page":"1860","article-title":"Report of the Committee on Hodgkin\u2019s disease staging.","volume":"31","author":"Carbone PP","year":"1971","journal-title":"Cancer Res."},{"key":"e_1_2_6_22_2","unstructured":"MasonDY&WoolsonRE.Double immuno\u2010enzymatic labeling. In: Bullock G Petrus P (eds.).Techniques in Immunocytochemistry Vol. 1. Academic London 1982; 135\u201352."},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1182\/blood.V91.11.4282","article-title":"A directly spliced exon 10\u2010containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non\u2010Hodgkin\u2019s lymphoma.","volume":"91","author":"Yakushijin Y","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1182\/blood.V85.10.2885.bloodjournal85102885","article-title":"CD44 variant isoforms in non\u2010Hodgkin\u2019s lymphoma: A new independent prognostic factor.","volume":"85","author":"Stauder R","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1128\/jvi.67.4.2209-2220.1993","article-title":"Epstein\u2010Barr virus induced genes: First lymphocyte specific G protein\u2010coupled peptide receptor.","volume":"67","author":"Birkenbach M","year":"1993","journal-title":"J. Virol."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401203"}],"container-title":["Pediatrics International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1442-200X.2001.01415.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1442-200X.2001.01415.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T23:04:22Z","timestamp":1697497462000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1442-200X.2001.01415.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,22]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8,22]]}},"alternative-id":["10.1046\/j.1442-200X.2001.01415.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1442-200x.2001.01415.x","archive":["Portico"],"relation":{},"ISSN":["1328-8067","1442-200X"],"issn-type":[{"value":"1328-8067","type":"print"},{"value":"1442-200X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,22]]}}}